percutaneous endoscopic gastrostomy
Recently Published Documents


TOTAL DOCUMENTS

2501
(FIVE YEARS 362)

H-INDEX

67
(FIVE YEARS 4)

2022 ◽  
Author(s):  
Shima Raeesi ◽  
Rezvan Hashemi ◽  
Zahra Vahabi ◽  
Mina Abdolahi ◽  
Mohsen Sedighiyan

Dementia is a progressive, disabling neurogenic disease that results in serious nutritional deficiencies included dysphagia, malnutrition, and weight loss. The Percutaneous Endoscopic Gastrostomy (PEG) is a long-term enteral feeding method that is routinely used in demented patients with poor food intake as a standard protocol. However, most of the pieces of evidence have not shown the beneficial effects of PEG feeding on complications or survival rates in these patients. Some studies have even reported an increase in mortality. The current systematic review and meta-analysis aimed to evaluate the mortality rate and survival in primary demented patients with PEG. A systematic search was conducted on Pubmed and Scopus databases up to Aug 2019. The data were reviewed according to the Cochrane handbook and preferred reporting items for systematic reviews and meta-analyses (PRISMA) and meta-analysis of observational studies in epidemiology (MOOSE). Based on the random-effects model, the mortality rate and median survival were expressed as risk ratio and weighted mean difference (WMD) and 95% CI, respectively. Among 13 included studies, PEG insertion in patients with primary dementia has no significant effect on 30-day, 90-day, 180-day, 1-year, and 2- year mortality rate or median survival (WMD: 9.77; 95% CI: -22.43 to 41.98; P=0.55). It seems that nasogastric tube (NGT) feeding in compared to PEG in this population is more effective. In conclusion, further prospective studies are needed for comprehensive evaluation of mortality or survival regarding comorbidities, underlying disease, cognitive and physical performance, and nutritional problems in demented patients.


2022 ◽  
Vol 2022 ◽  
pp. 1-2
Author(s):  
Celine Aslinia ◽  
Armand Edalati ◽  
Arianna Fallahian ◽  
Arya Edalati ◽  
Maha Hosseini

Gastrostomy tube placement in pregnancy is historically contraindicated due to risk of injury to the developing fetus and exposure to anesthetic agents. However, in cases where oral nutritional access is severely jeopardized, percutaneous endoscopic gastrostomy (PEG) tube placement can be a life-saving measure. In this case report and literature review, we present a case of successful PEG placement in a pregnant woman, followed by a discussion of the existing literature regarding PEG placement during pregnancy.


Cureus ◽  
2021 ◽  
Author(s):  
Jobin Philipose ◽  
Dhineshreddy Gurala ◽  
Abhishek D Polavarapu ◽  
Pretty Sara Idiculla ◽  
Vivek Gumaste

2021 ◽  
Vol 6 (3) ◽  
pp. 158-161
Author(s):  
Necattin FIRAT ◽  
Mehmet AZİRET ◽  
Barış MANTOĞLU ◽  
Recayi CAPOGLU ◽  
Hakan DEMİR ◽  
...  

2021 ◽  
Vol 46 ◽  
pp. S737
Author(s):  
A. Piñar-Gutiérrez ◽  
J.L. Pereira-Cunill ◽  
R. Vázquez-Gutiérrez ◽  
P. Serrano-Aguayo ◽  
P. Garrancho-Domínguez ◽  
...  

Author(s):  
Pedro Imbeth-Acosta ◽  
Mario Pineda ◽  
Zulay Mondol-Almeida ◽  
Alejandro Blanquicett ◽  
Kevin Llanos-Almario ◽  
...  

Gastrocolic fistulas represent a serious but rare complication of Percutaneous endoscopic gastrostomy (PEG). A 90-year-old male with multiple comorbidities and high preoperative risk develops one. He was successfully treated with expectant management.


Author(s):  
Rui Gaspar ◽  
Rosa Ramalho ◽  
Rosa Coelho ◽  
Patrícia Andrade ◽  
Miguel R. Goncalves ◽  
...  

<b><i>Introduction:</i></b> Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder with an inexorably progressive course which leads to a progressive neuromuscular weakness. Weight loss is one of the major bad prognostic factors in ALS. The placement of percutaneous endoscopic gastrostomy (PEG) is of paramount importance in patients with dysphagia to improve the disease outcomes, although some fear exists regarding the possible ventilatory complications during the procedure. The aim of this study was to evaluate the safety and effectiveness of PEG tube insertion under non-invasive ventilation (NIV) in patients with ALS and severe ventilatory impairment. <b><i>Methods:</i></b> A retrospective study of all consecutive PEGs placed in our department from May 2011 to January 2018 in patients with ALS was performed. The procedure was performed under non-invasive positive-pressure ventilation for ventilatory support. <b><i>Results:</i></b> We included 59 patients with ALS with severe ventilatory impairment, 58% were female, with a mean age of 67.2 ± 10.1 years and a median follow-up of 6 [2–15] months. The main indication for PEG placement was dysphagia (98%). The median time for PEG tube insertion since the established diagnosis of ALS was 12 [6–25] months and 4 [2–18] months since the beginning of bulbar symptoms. The majority of the patients had placed a 20-Fr PEG (63%) and under mild sedation with midazolam (80%), all under NIV. There were no immediate complications during and after the procedure (no episodes of aspiration or orotracheal intubation) and mortality. <b><i>Conclusion:</i></b> The placement of PEG is a very important procedure in patients with ALS and severe ventilatory impairment. The interdisciplinary department collaboration permitted the placement of PEG under NIV, in a safe and effective procedure in this special population.


Sign in / Sign up

Export Citation Format

Share Document